<code id='AB5DE082DD'></code><style id='AB5DE082DD'></style>
    • <acronym id='AB5DE082DD'></acronym>
      <center id='AB5DE082DD'><center id='AB5DE082DD'><tfoot id='AB5DE082DD'></tfoot></center><abbr id='AB5DE082DD'><dir id='AB5DE082DD'><tfoot id='AB5DE082DD'></tfoot><noframes id='AB5DE082DD'>

    • <optgroup id='AB5DE082DD'><strike id='AB5DE082DD'><sup id='AB5DE082DD'></sup></strike><code id='AB5DE082DD'></code></optgroup>
        1. <b id='AB5DE082DD'><label id='AB5DE082DD'><select id='AB5DE082DD'><dt id='AB5DE082DD'><span id='AB5DE082DD'></span></dt></select></label></b><u id='AB5DE082DD'></u>
          <i id='AB5DE082DD'><strike id='AB5DE082DD'><tt id='AB5DE082DD'><pre id='AB5DE082DD'></pre></tt></strike></i>

          fashion

          fashion

          author:fashion    Page View:1
          Adobe

          It is one of health care’s most vexing quandaries: Patient data must be shared to develop more effective medicines and artificial intelligence tools, but there’s no way to share it without violating privacy and basic data rights.

          Or is there?

          advertisement

          A fresh crop of companies is building a new data economy that enables the shared use of personal health information while enforcing ironclad privacy protections. They are not a monolithic group: each one uses its own methods and technologies, serves different customers, and is motivated by distinct problems and personal philosophies.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more
          Merck, Daiichi strike cancer drug pact worth up to $22 billion
          Merck, Daiichi strike cancer drug pact worth up to $22 billion

          KenaBetancur/GettyImagesMADRID—MerckispayingbillionsofdollarstopartnerwithDaiichiSankyoonaseriesofca

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          Cassava Sciences’ Alzheimer’s clinical trials should be halted

          MollyFerguson/STATTheFoodandDrugAdministrationshouldhaltCassavaSciences’ongoingclinicaltrialsinAlzhe